EW vs MS · P/E 47, rev $1.39B vs P/E 20, $344.27B cap
Edwards Lifesciences Corp (EW) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
MS does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the EW and MS stock pages for the full models.
Not investment advice.